Yuanwei Pan
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Biomedical Engineering top 2%
- Nanoplatforms for cancer theranostics
Papers in
- Immunology 20
- Immunotherapy and Immune Responses 8
- Immune cells in cancer 8
-
- Nanoplatforms for cancer theranostics 33
Yuanwei Pan
59 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 113
- Biomaterials 430
- Biomedical Engineering 1.2k
- Immunology 348
- Materials Chemistry 581
- Molecular Biology 592
Countries citing papers authored by Yuanwei Pan
This map shows the geographic impact of Yuanwei Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuanwei Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuanwei Pan more than expected).
Fields of papers citing papers by Yuanwei Pan
This network shows the impact of papers produced by Yuanwei Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuanwei Pan. The network helps show where Yuanwei Pan may publish in the future.
Co-authors
The 25 scholars most cited alongside Yuanwei Pan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 5 | |
| 3 | 2025 | 14 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 30 | |
| 6 | 2024 | 48 | |
| 7 | 2024 | 14 | |
| 8 | 2024 | 23 | |
| 9 | 2024 | 4 | |
| 10 | 2023 | 76 | |
| 11 | 2023 | 34 | |
| 12 | 2022 | 34 | |
| 13 | 2021 | 14 | |
| 14 | 2021 | 78 | |
| 15 | 2020 | 26 | |
| 16 | 2020 | 11 | |
| 17 | 2020 | 40 | |
| 18 | 2019 | 22 | |
| 19 | 2017 | 13 | |
| 20 | 2016 | 85 |
About Yuanwei Pan
Yuanwei Pan is a scholar working on Immunology, Biomedical Engineering, Biomaterials, Molecular Medicine and Molecular Biology, having authored 63 papers that have together received 1.9k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (33 papers), Extracellular vesicles in disease (11 papers), Immunotherapy and Immune Responses (8 papers), Immune cells in cancer (8 papers), RNA Interference and Gene Delivery (7 papers), Luminescence Properties of Advanced Materials (6 papers), Hydraulic Fracturing and Reservoir Analysis (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). The work is most often cited by research in Biomaterials (430 citations), Biomedical Engineering (1.2k citations), Immunology (348 citations), Materials Chemistry (581 citations) and Molecular Biology (592 citations). Yuanwei Pan has collaborated with scholars based in China, Germany and Singapore. Frequent co-authors include Lang Rao, Aiguo Wu, Leyong Zeng, Wenzhi Ren, Guangming Lu, Xiaoyuan Chen, Lujie Liu, Badri Parshad, Shouju Wang and Rainer Haag. Their work appears in journals such as Nanoscale, ACS Nano, Biomaterials, Theranostics and Advanced Healthcare Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.